Citius Pharmaceuticals, Inc.
SEC CIK 1506251 · CTXR · last insider filing 2025-09-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mazur Leonard L | Director · Executive Chairman | filed 2015 - 2025 |
| Holubiak Myron Z | Director · Vice Chairman | filed 2015 - 2025 |
| Mcgrath Dennis M | Director | filed 2023 - 2024 |
| Dutia Suren G | Director | filed 2015 - 2024 |
| Webb Carol | Director | filed 2016 - 2024 |
| Holuka Eugene Myron | Director | filed 2016 - 2024 |
| Smith Robert Joseph | Director | filed 2024 - 2024 |
| Safir Howard | Director | filed 2016 - 2022 |
| Kane William | Director | filed 2016 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bartushak Jaime | Chief Financial Officer | filed 2017 - 2024 |
| Czuczman Myron | Chief Medical Officer | filed 2020 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.